TrialLancet (London, England)2023

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.

Kohei Nakachi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.